Houston, TX 的 腸胃道癌症 臨床試驗
21 項針對 腸胃道癌症 的研究正在 Houston（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
招募中3 期
- GSK Investigational Site, Houston
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
招募中2 期
- The University of Texas MD Anderson Cancer Center - Texas Medical Center, Houston
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
招募中3 期
- Oncology Consultants P.A., Houston
- Oncology Consultants P.A., Houston
- Texas Oncology - Gulf Coast, Houston
- 還有 7 項
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
招募中1/2 期
- Baylor College of Medicine, Houston
- The University of Texas MD Anderson Cancer Center, Houston
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
招募中1/2 期
- MD Anderson, Houston
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
招募中1/2 期
- The University of Texas, MD Anderson Cancer Center, Houston
A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
招募中1/2 期
- GSK Investigational Site, Houston
Evaluation of Portal Vein Stenting in Patients With Portal Vein Stenosis and Gastrointestinal Cancers
招募中觀察性研究
- M D Anderson Cancer Center, Houston
Goals of Care Discussion for Patients With Advanced Lung and Gastrointestinal Cancer in the Emergency Department of a Comprehensive Cancer Center
招募中
- MD Anderson Cancer Center, Houston
A First in Human Study of PLT012 in Participants With Solid Tumor Cancers
招募中1 期
- MD Anderson Cancer Center, Houston
- NEXT Houston, Houston
Telephone Support in Advanced Gastrointestinal Cancer
招募中
- MD Anderson Cancer Center, Houston
Improving Comprehensive Care of Cancer Patients
招募中歡迎健康志工
- Baylor College of Medicine, Houston
BOLSTER: Learning New Skills to Thrive
招募中
- The University of Texas MD Anderson Cancer Center, Houston
Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy
招募中觀察性研究
- M D Anderson Cancer Center, Houston
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
招募中1 期
- University of Texas, MD Anderson Cancer Center, Houston
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
招募中1/2 期
- MD Anderson Cancer Center, Houston
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
招募中1/2 期
- The University of Texas MD Anderson Cancer Center, Houston
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
招募中1/2 期
- MD Anderson Cancer Center, Houston
Molecular Epidemiology of Biliary Tree Cancers
招募中觀察性研究
- M D Anderson Cancer Center, Houston
Traction vs. No Traction in Colonic ESD
招募中
- Baylor College of Medicine, Houston
- Baylor St. Lukes Medical Center (BSLMC), Houston
Novel Rigidizing Overtube in Colonic Endoscopic Submucosal Dissection
招募中
- Baylor College of Medicine, Houston
- Baylor St. Lukes Medical Center (BSLMC), Houston
其他城市的 腸胃道癌症 試驗
- Boston, MA15 項研究
- New York City, NY12 項研究
- Nashville, TN10 項研究
- Los Angeles, CA9 項研究
- Dallas, TX8 項研究
- Cincinnati, OH8 項研究
- Durham, NC8 項研究
- Baltimore, MD8 項研究
- Arlington, VA8 項研究
- Baldwin Park, CA7 項研究
- Seattle, WA7 項研究
- San Antonio, TX7 項研究
Houston 的其他研究
- 非小細胞肺癌145 項研究
- 乳癌126 項研究
- 癌症（所有類型）121 項研究
- 轉移性癌症104 項研究
- 大腸直腸癌102 項研究
- 卵巢癌89 項研究
- 急性髓系白血病85 項研究
- 肺癌78 項研究
- 前列腺癌76 項研究
- 子宮內膜癌68 項研究
- 胰臟癌61 項研究
- 黑色素瘤59 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。